28254372|t|Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency
28254372|a|Systemic drug delivery to a solid tumor involves a sequence of steps that determine efficacy and survival. Extravasation from circulation at the tumor site is a critical step in this sequence since it regulates how much of the drug accumulates in the tumor. Despite its importance in determining outcomes, extravasation from circulation remains a "black box." The objective of this study is to develop predictive tools for optimization of drug delivery systems. By comparing pharmacokinetics of liposomal doxorubicin in tumor -free and tumor bearing mice we quantitatively assess the rate constants for distribution, elimination, and tumor accumulation. We then relate these rate constants to the tumor -type and drug delivery system. We compare tumor accumulation in three tumor types and show a 10-fold difference between a colorectal adenocarcinoma and a pancreatic adenocarcinoma. Finally, we show how quantitative predictions of changes in tumor accumulation can be used to optimize drug delivery system s.
28254372	0	5	Tumor	T038	UMLS:C0027651
28254372	6	18	accumulation	T033	UMLS:C4055506
28254372	22	43	liposomal doxorubicin	T103	UMLS:C0717726
28254372	53	59	murine	T204	UMLS:C0026809
28254372	60	66	models	T204	UMLS:C0599779
28254372	79	87	delivery	T074	UMLS:C0085104
28254372	108	121	drug delivery	T074	UMLS:C0085104
28254372	127	138	solid tumor	T038	UMLS:C0280100
28254372	206	219	Extravasation	T038	UMLS:C0015376
28254372	225	236	circulation	T038	UMLS:C1516559
28254372	244	249	tumor	T038	UMLS:C0027651
28254372	350	355	tumor	T038	UMLS:C0027651
28254372	405	418	extravasation	T038	UMLS:C0015376
28254372	424	435	circulation	T038	UMLS:C1516559
28254372	481	486	study	T062	UMLS:C0008972
28254372	538	559	drug delivery systems	T074	UMLS:C0085104
28254372	574	590	pharmacokinetics	T038	UMLS:C0031327
28254372	594	615	liposomal doxorubicin	T103	UMLS:C0717726
28254372	619	624	tumor	T038	UMLS:C0027651
28254372	635	640	tumor	T038	UMLS:C0027651
28254372	649	653	mice	T204	UMLS:C0026809
28254372	733	738	tumor	T038	UMLS:C0027651
28254372	739	751	accumulation	T033	UMLS:C4055506
28254372	796	801	tumor	T038	UMLS:C0027651
28254372	812	832	drug delivery system	T074	UMLS:C0085104
28254372	845	850	tumor	T038	UMLS:C0027651
28254372	851	863	accumulation	T033	UMLS:C4055506
28254372	873	878	tumor	T038	UMLS:C0027651
28254372	925	950	colorectal adenocarcinoma	T038	UMLS:C1319315
28254372	957	982	pancreatic adenocarcinoma	T038	UMLS:C0281361
28254372	1044	1049	tumor	T038	UMLS:C0027651
28254372	1050	1062	accumulation	T033	UMLS:C4055506
28254372	1087	1107	drug delivery system	T074	UMLS:C0085104